Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on May 05, 2025
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India held its 2nd Annual General Meeting on May 5, 2025, via video conferencing from 3:30 p.m. to 5:30 p.m. (IST), chaired by Mr. Amit Jain. Managing Director Mr. Himanshu Bakshi addressed shareholders on business performance, growth opportunities, and outlook. Seven ordinary resolutions were transacted, including approval of audited financial statements for FY ending December 31, 2024, declaration of a final dividend of Rs. 55 per equity share (on Rs. 10 face value), and re-appointment of directors Ms. Carol-Ann Stewart and Mr. Himanshu Bakshi. Other items included ratification of cost auditor remuneration, appointment of a secretarial auditor, and approval of commission for non-executive directors. Ten speaker shareholders participated in the Q&A session before the meeting concluded.
The key shareholder takeaway is the final dividend of Rs. 55 per share (a 550% payout on face value), which signals strong financial health. The meeting appears to be a routine compliance filing with no contentious issues raised, so the stock impact is likely neutral to mildly positive given the generous dividend.